EEG patterns in each phase of hemiplegic migraine: a systematic review and pooled prevalence meta-analysis
Abstract
Introduction: Hemiplegic migraine (HM) is a rare subtype of migraine with aura, and its pathophysiology is similar to that of migraine with aura, primarily involving cortical spreading depression. Electroencephalography (EEG) may serve as a valuable tool for investigating brain function in patients with hemiplegic migraine. Therefore, this study aims to synthesize available evidence through a systematic review and pooled prevalence meta-analysis to assess the types of EEG abnormalities observed in each migraine phase in patients with hemiplegic migraine and to estimate the prevalence of EEG abnormalities during the interictal period.
Method: We searched PubMed, Scopus, and Cochrane up to January 2025 and included articles, including case reports, case series, and retrospective studies that reported EEG abnormalities in hemiplegic migraine. The prevalence of abnormal EEG during the interictal phase was analyzed through pooled data analysis.
Result: A total of 40 articles involving 65 patients were included in the analysis. The most common EEG abnormality During the aura phase was low-amplitude activity affecting the hemisphere contralateral to the hemiparesis, observed in 71.4% (5/7) of cases. Similarly, During the headache and post-headache phases, the most frequently observed EEG abnormality was medium- to high-amplitude slowing, particularly in the hemisphere contralateral to the hemiparesis, occurring in 54.9% (28/51) and 37.5% (9/24) of cases, respectively. Meanwhile,…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 65 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.